About Support Contact FAQ

Links

Subjects

Cardiology and Cardiovascular Medicine

Pulmonary and Respiratory Medicine

Transplantation

Surgery

Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension

The Journal of Heart and Lung Transplantation, 2020, 39, 1389-1397

Michele D'Alto, Roberto Badagliacca, Francesco Lo Giudice, Paola Argiento, Gavino Casu, Marco Corda, Michele Correale, Stefano Ghio, Alessandra Greco, Mariangela Lattanzio, Valentina Mercurio, Giuseppe Paciocco, Silvia Papa, Renato Prediletto, Emanuele Romeo, Maria Giovanna Russo, Alessandro Tayar, Patrizio Vitulo, Carmine Dario Vizza, Paolo Golino, Robert Naeije

Citation of paper, Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension

Authors Citing This Paper

Author	Citing Papers	Author's Papers	Author's Citations	Author's IF
Gianmarco SCOCCIA	1	7	27	3.3
Vizzadario	1	144	8,030	8.7

Journals Citing This Paper

Journal	Citing Papers	Journal's IF	Journal's Star
Journal of Clinical Medicine	1	3.5

Similar Articles

2015

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

New England Journal of Medicine (24.9 1209★★★), 373, 834-844.

Irène Frachon (25, 8.3)Nedim Selimovic (20, 7)Marius M. Hoeper (251, 12)Stefan Söderberg (177, 17.7)Hossein A. Ghofrani (393, 9.5)Vizzadario (144, 8.7)Pascal de Groote (138, 7.1)Laila Hübbert (22, 11.3)Julia Harris (6, 23.7)Galie’ Nazzareno (164, 19.3)

General Medicine

2018

Initial tadalafil and ambrisentan combination therapy in pulmonary arterial hypertension

Journal of Cardiovascular Medicine (0.6 42★), 19, 12-17.

Michele D'Alto (110, 3.6)Stefano Ghio (182, 6.4)Alessandra Greco (14, 0.8)Vizzadario (144, 8.7)Michele Correale (163, 2.3)

General Medicine Cardiology and Cardiovascular Medicine

2021

Recent advances in the management of pulmonary arterial hypertension: lessons from the upfront combination of ambrisentan and tadalafil

Expert Review of Respiratory Medicine (3.5 44), 15, 493-504.

Pilar Escribano Subías (98, 2)

Public Health, Environmental and Occupational Health Pulmonary and Respiratory Medicine Immunology and Allergy

2018

Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension

American Journal of Respiratory and Critical Care Medicine (5.8 421★★), 197, 388-391.

Pulmonary and Respiratory Medicine Critical Care and Intensive Care Medicine

2014

Randomized study of adding tadalafil to existing ambrisentan in pulmonary arterial hypertension

Hypertension Research (2.8 95★), 37, 507-512.

Yu-Gang Zhuang (11, 1.5)

Cardiology and Cardiovascular Medicine Physiology Internal Medicine

2011

Long-Term Pulmonary Hemodynamic Effects of Ambrisentan in Pulmonary Arterial Hypertension

The American Journal of Cardiology (1.9 299★), 108, 302-307.

Cardiology and Cardiovascular Medicine

2005

Ambrisentan for pulmonary arterial hypertension

Future Cardiology (1.2 36), 1, 425-432.

Cardiology and Cardiovascular Medicine Molecular Medicine

Quick Tips

This is an overview of where and by who this paper has been cited.

Help Us

Non-profit projects normally ask for donations. We don't. We will survive one way or another. If you wish to help us, please spread the word to let more people use this service.

It is delightful to see our efforts are useful to a broad range of researchers.

EXALY

Terms of Service

Authors

Journals

by Impact Factor

Institutions

by Publications

by Avg Impact Factor

by 2-star Articles

by 3-star Articles

site/software © exaly; All materials licenced under CC by-SA.